How a Peninsula Company Puzzled Out a New Biotech Model around Potential Eye, Heart Drugs
A feature story about Maze Therapeutics, led by CEO Jason Coloma T’07, and two joint ventures it pursued with BridgeBio Pharma and Alloy Therapeutics.
Dec 07, 2020